• citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:34
  • full-text downloads in 30 days:12


article: 1 from 39  
Back back to result list
2022, vol. 19, iss. 1, pp. 4-8
Increased incidence of urinary tract infections caused by Enterococcus in COVID-19 patients of the Clinical Center of Vojvodina
aUniverzitet u Novom Sadu, Medicinski fakultet, Katedra za mikrobiologiju sa parazitologijom i imunologijom, Novi Sad + Institut za javno zdravlje Vojvodine, Novi Sad
bInstitut za javno zdravlje Vojvodine, Novi Sad
cUniverzitet u Novom Sadu, Medicinski fakultet, Katedra za mikrobiologiju sa parazitologijom i imunologijom, Novi Sad + Pasterov zavod, Služba za prevenciju i sprečavanje širenja, Novi Sad
Objective. To investigate the frequency of isolates of various uropathogens in patients of the COVID-19 Hospital "Mišeluk" in comparison with patients from the nonCOVID-19 zone of the Clinical Center of Vojvodina (KCV). Methods. For the purpose of this study, information was collected on urine isolates sent from the COVID-19 hospital and the non-COVID-19 zones of the Clinical Center of Vojvodina in a three-month period, with samples from the non-COVID-19 zone KCV used as controls. Results. Of the 449 patients from the COVID-19 Hospital, the most common causative agents of intrahospital urinary infection (IUI) were members of the genus Enterococcus, (216/449; 48.10%), which in most cases caused IUI in women (127/216; 58.79%). The second most common causative agent of IUT in COVID-19 was Klebsiella pneumoniae (85/449; 18.93%). Of the 913 patients from the non-COVID-19 KCV clinics, the most common cause of IUI was Escherichia coli (249/913; 27.27%), predominantly in women (199/249; 79.91%, (ch2 (1) = 49,042). p <0.00001)). The second most frequent causative agents of IUTs were members of the genus Enterococcus, (216/913; 23.65%), with no significant difference in distribution between the sexes (ch2 (1) = 0.0833; p = 0.847). Conclusion. The most common causes of IUI in the COVID-19 KCV hospital were members of the genera Enterococcus and Klebsiella pneumoniae with almost equal distribution between the sexes. There was a statistically significant difference in the frequency of different IUI agents in the COVID-19 hospital patients versus the nonCOVID-19 KCV clinics. These results may be important in determining empirical therapy in patients of the COVID-19 KCV Hospital, as well as in planning procedures for the reduction of nosocomial infections.
Article uploaded retrospectively: references checking, normalizing and linking in progress.
lores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13: 269-84.
Woldemariam HK, Geleta DA, Tulu KD, et al. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis 2019; 19: 43.
Stefaniuk E, Suchocka U, Bosacka K, Hryniewicz W. Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland. Eur J Clin Microbiol Infect Dis 2016; 35: 1363-9.
Rizwan M, Akhtar M, Najmi AK, Singh K. Escherichia coli and Klebsiella pneumoniae sensitivity/resistance pattern towards antimicrobial agents in primary and simple urinary tract infection patients visiting University Hospital of Jamia Hamdard New Delhi. Drug Res 2018; 68: 415-20.
Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari Cheshmeh M, Salehian Omran D. A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica 2010; 5: 111-5.
Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-e120.
Karaba SM, Jones G, Helsel T, et al. Prevalence of coinfection at the time of hospital admission in COVID-19 patients, a multicenter study. Open Forum Infect Dis 2021; 8: ofaa578.
Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2021; 27: 83-8.
Bardi T, Pintado V, Gomez-Rojo M, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect 2021; 40: 495-502.
Zuglian G, Ripamonti D, Tebaldi A, et al. The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit. BMC Infect Dis 2022; 22: 185.
DeVoe C, Segal MR, Wang L, et al. Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol 2022; 43: 1416-23.


article language: Serbian
document type: Original Scientific Paper
DOI: 10.5937/pomc19-37033
received: 18/03/2022
accepted: 14/04/2022
published in SCIndeks: 17/02/2023

Related records

No related records